Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.
Lundkvist P, Sjöström CD, Amini S, Pereira MJ, Johnsson E, Eriksson JW. Lundkvist P, et al. Diabetes Obes Metab. 2017 Jan;19(1):49-60. doi: 10.1111/dom.12779. Epub 2016 Sep 26. Diabetes Obes Metab. 2017. PMID: 27550386 Free PMC article. Clinical Trial.
A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss.
Pereira MJ, Lundkvist P, Kamble PG, Lau J, Martins JG, Sjöström CD, Schnecke V, Walentinsson A, Johnsson E, Eriksson JW. Pereira MJ, et al. Among authors: lundkvist p. Diabetes Ther. 2018 Aug;9(4):1511-1532. doi: 10.1007/s13300-018-0449-6. Epub 2018 Jun 13. Diabetes Ther. 2018. PMID: 29949016 Free PMC article.
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
Eriksson JW, Lundkvist P, Jansson PA, Johansson L, Kvarnström M, Moris L, Miliotis T, Forsberg GB, Risérus U, Lind L, Oscarsson J. Eriksson JW, et al. Among authors: lundkvist p. Diabetologia. 2018 Sep;61(9):1923-1934. doi: 10.1007/s00125-018-4675-2. Epub 2018 Jul 3. Diabetologia. 2018. PMID: 29971527 Free PMC article. Clinical Trial.
Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover.
Kamble PG, Pereira MJ, Gustafsson S, Lundkvist P, Castillejo-López C, Fall T, Ingelsson E, Eriksson JW. Kamble PG, et al. Among authors: lundkvist p. Adipocyte. 2018;7(4):285-296. doi: 10.1080/21623945.2018.1503030. Epub 2018 Aug 14. Adipocyte. 2018. PMID: 30064293 Free PMC article.
16 results